Recent Reports


2011-11-14: Biotechnology and Pharmaceuticals Report
5 leading Analysts; and top management from 4 Sector Firms examine this industry.
Order this Report
More Information

2011-10-31: Health Care IT Report
4 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-10-17: Medical Research, Diagnostic Substances & Life Science Tools Report
4 leading Analysts; and top management from 3 Sector Firms examine this industry.
Order this Report
More Information

2011-10-03: Medical Real Estate Report
3 leading Analysts; and top management from 3 Sector Firms examine industry.
Order this Report
More Information

2011-07-11: Medical Devices Report
5 leading Analysts; and top management from 12 Sector Firms examine this industry.
Order this Report
More Information

2011-06-27: Health Care IT Report
6 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

2011-06-13: Medical Research, Diagnostic Substances & Life Science Tools Report
5 leading Analysts; and top management from 3 Sector Firm examine this industry.
Order this Report
More Information

2011-04-04: Biotechnology and Pharmaceuticals Report
3 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-01-24: Medical Devices Report
3 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Money Manager Interview Excerpt
SEEKING HEALTHCARE REFORM'S WINNER – EDWARD YOON – FIDELITY INVESTMENTS


Full article published: 08/24/2009


For Subscribers

Get this article online now!

Order just this article
TWST: What is the history of your asset management fund and its philosophy?
Mr. Yoon: I would say Fidelity's fund management family, at its core, represents a bottom-up, research-driven process that depends upon analysts. We have an enormous analyst team. What we do is bottom-up stock-picking work - we go out, we research companies and markets and we try to construct the best portfolios from a bottom-up perspective.

TWST: Would you describe your investment criteria and expected return?
Mr. Yoon: I am on a diversified healthcare fund, that is the sector fund. My investment philosophy as it relates to healthcare is on the product side of the house, you need to be a growth investor and you need to find good product cycles; you have to find good end-markets, you need to find companies that are generally better-than-average deployers of capital, given how cash generative these companies are. And then on the service side, which is a little bit of a different kind of a business model, we're looking for defensible businesses that generate strong returns at reasonable valuations, so that's sort of the discipline.

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.